Fundz

Arsenal Biosciences reported raising $325 Million in an initial SEC Form D filing, from an offering of $325 Million

PRIVATESep 04, 2024

Amount Raised

$325 Million

$325 Million sold, per SEC Form D (first sale Jul 9, 2024)

Round Type

Venture

South San FranciscoBiotechnologyHealth CareTherapeutics

Quick answer

Arsenal Biosciences raised $325 Million in a funding round, dated July 9, 2024. Arsenal Biosciences is based in South San Francisco, California, United States.

How much did Arsenal Biosciences raise?
Arsenal Biosciences raised $325 Million in a funding round on July 9, 2024.
What does Arsenal Biosciences do?
Arsenal Biosciences, Inc. (ArsenalBio), headquartered in South San Francisco, Calif., is a privately held programmable cell therapy company discovering and developing a pipeline of next-generation autologous T cell..
Where is Arsenal Biosciences based and how big is it?
Arsenal Biosciences is based in South San Francisco, California, United States.
Who are the decision-makers at Arsenal Biosciences?
Fundz holds 1 contact at Arsenal Biosciences, including the Chairman, CEO, Co-Founder. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Arsenal Biosciences that raised within 45 days of this round, from Fundz verified event records.

  • Navigator Medicines raised $50M on August 23, 2024.
  • Borealis Biosciences raised $150M (Series A) on August 22, 2024.
  • Pathalys Pharma raised $105M (Series B) on August 21, 2024.
  • Retension Pharmaceuticals raised $10M (Series A) on August 21, 2024.
  • Candid Therapeutics raised $206M on August 19, 2024.
  • IDRx raised $120M (Series B) on August 7, 2024.

Who to call at Arsenal Biosciences, and when

A new round usually means Arsenal Biosciences is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Arsenal Biosciences raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Arsenal Biosciences, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Arsenal Biosciences. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Arsenal Biosciences

Location

329 Oyster Point Blvd

South San Francisco, California, United States

About

Arsenal Biosciences, Inc. (ArsenalBio), headquartered in South San Francisco, Calif., is a privately held programmable cell therapy company discovering and developing a pipeline of next-generation autologous T cell therapies to defeat cancer. Our full-stack R&D engine generates multifunctional T cell medicines, enabled by precise and specific CRISPR insertion of large synthetic DNA sequences. ArsenalBio is building the industry’s largest DNA library of therapeutic enhancing integrated circuits, incorporating logic gating for improved tumor targeting and synthetic features enabling multiple pharmaceutical functions. In pioneering a computationally driven approach alongside nonviral clinical manufacturing, we aspire to deliver enhanced efficacy, increased patient safety, reduced stakeholder costs, and expanded market access.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Arsenal Biosciences raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Verified contactsKen D., Chairman, CEO, Co-Founder hiddenSee plans and pricing
Predictive Intelligence
Strategic

ML-powered predictions for Arsenal Biosciences's next move

See what Strategic adds

Arsenal Biosciences raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.